View in EDS HTML Full Text PDF Full Text

Relevance of AKT and RAS Signaling Pathways for Antibody–Drug Conjugate Immunotherapies in Acute Lymphoblastic Leukemia.

Saved in:
Bibliographic Details
Title: Relevance of AKT and RAS Signaling Pathways for Antibody–Drug Conjugate Immunotherapies in Acute Lymphoblastic Leukemia.
Authors: Ehm, Patrick A. H.1 (AUTHOR) p.trickehm@gmail.com, Rehbach, Christoph2 (AUTHOR)
Source: Lymphatics. Dec2025, Vol. 3 Issue 4, p33. 43p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:28133307
DOI:10.3390/lymphatics3040033